SHR-A2009 plus EGFR tyrosine kinase inhibitor shows promising activity in EGFR-mutant lung cancer

Sevabertinib shows manageable diarrhoea without impacting efficacy in HER2-mutant lung cancer

Subcutaneous amivantamab plus lazertinib shows durable responses in EGFR-mutant advanced lung cancer

Distinct lung microbiome patterns identified in Portuguese patients with lung cancer

Artificial intelligence PD-L1 scoring matches pathologists and improves reproducibility in lung cancer testing

T-cell engagers in lung cancer: Strategies to prevent and manage toxicities

Education and training in breast cancer care

Low-dose CT screening reduces lung cancer mortality and improves survival in broad populations

Cracking the code: Bispecific immunotherapy in small cell lung cancer

ATR inhibitor plus durvalumab does not improve survival over docetaxel in advanced NSCLC

Durvalumab after SBRT reduces tumour progression in early-stage NSCLC

Gotistobart improves survival and response over docetaxel in previously treated squamous lung cancer